p53 and treatment of bladder cancer.
Cote
R J
RJ
Esrig
D
D
Groshen
S
S
Jones
P A
PA
Skinner
D G
DG
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000235:genetics; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000235:genetics*; D017024:Chemotherapy, Adjuvant; D004247:DNA / Q000187:drug effects; D016158:Genes, p53; D006801:Humans; D009154:Mutation; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000235:genetics*
D000970:Antineoplastic Agents; D004247:DNA